Rotavirus NSP1 Mediates Degradation of Interferon Regulatory Factors through Targeting of the Dimerization Domain

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9813-9821

  Arnold, Michelle M ^a,b   Barro, Mario ^a,c   Patton, John T ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; NONSTRUCTURAL PROTEIN 1; STAT PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TARGETING; ROTAVIRUS; VIRUS IMMUNITY;

ADAPTIVE IMMUNITY; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON REGULATORY FACTORS; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; ROTAVIRUS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84883289749     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01146-13     Document Type: Article

References (65)

1. Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59:489-510.
2. Yanai H, Mizutani T, Inuzuka T, Honda K, Takaoka A, Taniguchi T. 2005. IRF family transcription factors in type I interferon induction. Int. Congr. Ser. 1285:104-113.
3. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548.
4. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K, Taniguchi T. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. U. S. A. 104:3402-3407.
5. Paun A, Pitha PM. 2007. The IRF family, revisited. Biochimie 89:744-753.
6. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. 2011. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3:920-940.
7. Jensen S, Thomsen AR. 2012. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J. Virol. 86:2900-2910.
8. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20:4-22.
9. Schlee M, Barchet W, Hornung V, Hartmann G. 2007. Beyond doublestranded RNA-type I IFN induction by pppRNA and other viral nucleic acids. Curr. Top. Microbiol. Immunol. 316:207-230.
10. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
11. Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Kirchhoff S, Hauser H, Nagulapalli S, Atchison ML, Levi BZ. 1999. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163:6468-6478.
12. Yanai H, Negishi H, Taniguchi T. 2012. The IRF family of transcription factors: inception, impact and implications in oncogenesis. Oncoimmunology 1:1376-1386.
13. Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T. 1999. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 18:5028-5041.
14. Panne D, Maniatis T, Harrison SC. 2007. An atomic model of the interferon-beta enhanceosome. Cell 129:1111-1123.
15. Escalante CR, Yie J, Thanos D, Aggarwal AK. 1998. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391:103-106.
16. Qin BY, Liu C, Lam SS, Srinath H, Delston R, Correia JJ, Derynck R, Lin K. 2003. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10:913-921.
17. Brierley MM, Fish EN. 2005. Stats: multifaceted regulators of transcription. J. Interferon Cytokine Res. 25:733-744.
18. Reich NC. 2002. Nuclear/cytoplasmic localization of IRFs in response to viral infection or interferon stimulation. J. Interferon Cytokine Res. 22: 103-109.
19. Barnes BJ, Kellum MJ, Field AE, Pitha PM. 2002. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22:5721-5740.
20. Lin R, Mamane Y, Hiscott J. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19:2465-2474.
21. Lin R, Genin P, Mamane Y, Hiscott J. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:6342-6353.
22. Takahasi K, Suzuki NN, Horiuchi M, Mori M, Suhara W, Okabe Y, Fukuhara Y, Terasawa H, Akira S, Fujita T, Inagaki F. 2003. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10:922-927.
23. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, Fitzgerald KA, Lin K, Royer WE, Jr. 2008. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 15:1213-1220.
24. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
25. Greenberg HB, Estes MK. 2009. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136:1939-1951.
26. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-Coordinated Global Rotavirus Surveillance Network. 2012. 2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 12:136-141.
27. Angel J, Franco MA, Greenberg HB. 2012. Rotavirus immune responses and correlates of protection. Curr. Opin. Virol. 2:419-425.
28. Broquet AH, Hirata Y, McAllister CS, Kagnoff MF. 2011. RIG-I/MDA5/ MAVS are required to signal a protective IFN response in rotavirusinfected intestinal epithelium. J. Immunol. 186:1618-1626.
29. Sen A, Pruijssers AJ, Dermody TS, Garcĺa-Sastre A, Greenberg HB. 2011. The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J. Virol. 85:3717-3732.
30. Arnold MM, Sen A, Greenberg HB, Patton JT. 2013. The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog. 9:e1003064. doi:10.1371/journal.ppat.1003064.
31. Sherry B. 2009. Rotavirus and reovirus modulation of the interferon response. J. Interferon Cytokine Res. 29:559-567.
32. Hu L, Crawford SE, Hyser JM, Estes MK, Prasad BV. 2012. Rotavirus non-structural proteins: structure and function. Curr. Opin. Virol. 2:380-388.
33. Mansur DS, Maluquer de Motes C, Unterholzner L, Sumner RP, Ferguson BJ, Ren H, Strnadova P, Bowie AG, Smith GL. 2013. Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog. 9:e1003183. doi:10.1371/journal.ppat.1003183.
34. Graff JW, Ettayebi K, Hardy ME. 2009. Rotavirus NSP1 inhibits NF-kB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog. 5:e1000280. doi:10 .1371/journal.ppat.1000280. Arnold et al.
35. Graff JW, Mitzel DN, Weisend CM, Flenniken ML, Hardy ME. 2002. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J. Virol. 76:9545-9550.
36. Feng N, Sen A, Nguyen H, Vo P, Hoshino Y, Deal EM, Greenberg HB. 2009. Variation in antagonism of the interferon response to rotavirus NSP1 results in differential infectivity in mouse embryonic fibroblasts. J. Virol. 83:6987-6994.
37. Barro M, Patton JT. 2005. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. U. S. A. 102:4114-4119.
38. Barro M, Patton JT. 2007. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J. Virol. 81:4473-4481.
39. Arnold MM, Patton JT. 2011. Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains. J. Virol. 85: 1970-1979.
40. Sen A, Feng N, Ettayebi K, Hardy ME, Greenberg HB. 2009. IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J. Virol. 83:10322-10335.
41. Hua J, Mansell EA, Patton JT. 1993. Comparative analysis of the rotavirus NS53 gene: conservation of basic and cysteine-rich regions in the protein and possible stem-loop structures in the RNA. Virology 196:372-378.
42. Xu L, Tian Y, Tarlow O, Harbour D, McCrae MA. 1994. Molecular biology of rotaviruses. IX. Conservation and divergence in genome segment 5. J. Gen. Virol. 75:3413-3421.
43. Dunn SJ, Cross TL, Greenberg HB. 1994. Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology 203:178-183.
44. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
45. Patton JT, Taraporewala Z, Chen D, Chizhikov V, Jones M, Elhelu A, Collins M, Kearney K, Wagner M, Hoshino Y, Gouvea V. 2001. Effect of intragenic rearrangement and changes in the 3' consensus sequence on NSP1 expression and rotavirus replication. J. Virol. 75:2076-2086.
46. Small C, Barro M, Brown TL, Patton JT. 2007. Genome heterogeneity of SA11 rotavirus due to reassortment with "O" agent. Virology 359:415-424.
47. Mori M, Yoneyama M, Ito T, Takahashi K, Inagaki F, Fujita T. 2004. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279:9698-9702.
48. Lu R. 2008. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 29:487-492.
49. Holloway G, Truong TT, Coulson BS. 2009. Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kB, J. Virol. 83:4942-4951.
50. Donnelly RP, Kotenko SV. 2010. Interferon-lambda: a new addition to an old family. J. Interferon Cytokine Res. 30:555-564.
51. Pott J, Mahlakõiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, Staeheli P, Hornef MW. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U. S. A. 108:7944-7949.
52. Iversen MB, Paludan SR. 2010. Mechanisms of type III interferon expression. J. Interferon Cytokine Res. 30:573-578.
53. Aravind L, Iyer LM, Koonin EV. 2003. Scores of RINGS but no PHDs in ubiquitin signaling. Cell Cycle 2:123-126.
54. Pina-Vazquez C, De Nova-Ocampo M, Guzman-Leon S, Padilla-Noriega L. 2007. Post-translational regulation of rotavirus protein NSP1 expression in mammalian cells. Arch. Virol. 152:345-368.
55. Eroshkin A, Mushegian A. 1999. Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens. J. Mol. Med. (Berlin) 77:403-405.
56. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K. 1998. Smad proteins exist as monomers in vivo and undergo homo-and heterooligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:4056-4065.
57. Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, Lin K. 2001. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat. Struct. Biol. 8:248-253.
58. Qin BY, Chacko BM, Lam SS, de Caestecker MP, Correia JJ, Lin K. 2001. Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 8:1303-1312.
59. Qing J, Liu C, Choy L, Wu RY, Pagano JS, Derynck R. 2004. Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol. Cell. Biol. 24:1411-1425.
60. Bhowmick R, Halder UC, Chattopadhyay S, Nayak MK, Chawla-Sarkar M. 2013. Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53. J. Virol. 87:6840-6850.
61. Bagchi P, Dutta D, Chattopadhyay S, Mukherjee A, Halder UC, Sarkar S, Kobayashi N, Komoto S, Taniguchi K, Chawla-Sarkar M. 2010. Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J. Virol. 84:6834-6845.
62. Bagchi P, Nandi S, Nayak MK, Chawla-Sarkar M. 2013. Molecular mechanism behind rotavirus NSP1-mediated PI3 kinase activation: interaction between NSP1 and the p85 subunit of PI3 kinase. J. Virol. 87:2358-2362.
63. Qin L, Ren L, Zhou Z, Lei X, Chen L, Xue Q, Liu X, Wang J, Hung T. 2011. Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I. Virol. J. 8:526.
64. Hua J, Chen X, Patton JT. 1994. Deletion mapping of the rotavirus metalloprotein NS53 (NSP1): the conserved cysteine-rich region is essential for virus-specific RNA binding. J. Virol. 68:3990-4000.
65. Zhang R, Jha BK, Ogden KM, Dong B, Zhao L, Elliott R, Patton JT, Silverman RH, Weiss SR. Homologous 2', 5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A., in press.